These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3439212)

  • 41. [Cardiovascular examination of 40-year-old subjects in Hordaland].
    Njølstad I
    Tidsskr Nor Laegeforen; 1995 Jan; 115(2):270-1. PubMed ID: 7855825
    [No Abstract]   [Full Text] [Related]  

  • 42. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
    Rabinowitz I; Tamir A
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hypertension management in general practice in Iceland].
    Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
    Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between QT interval and cardiovascular risk factors in healthy young subjects.
    Leotta G; Maule S; Rabbia F; Del Colle S; Tredici M; Canadè A; Verhovez A; Veglio F
    J Hum Hypertens; 2005 Aug; 19(8):623-7. PubMed ID: 15905890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Psychosocial consequences of screening for microalbuminuria and for some other risk factors].
    Tijmstra T; Spijkers W; Broer J; Janssen WM; de Jong PE
    Ned Tijdschr Geneeskd; 2000 Dec; 144(51):2460-4. PubMed ID: 11151656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Control of systolic blood pressure in the VALUE trial after 12 months].
    Schmieder RE; Handrock R;
    Dtsch Med Wochenschr; 2003 Mar; 128(10):485-6. PubMed ID: 12627338
    [No Abstract]   [Full Text] [Related]  

  • 47. [Prevention of cardiovascular diseases--easier to say than to do].
    Braut GS
    Tidsskr Nor Laegeforen; 1995 Feb; 115(4):518-9. PubMed ID: 7871514
    [No Abstract]   [Full Text] [Related]  

  • 48. [Cardiovascular preparticipation screening of competitive athletes].
    Heinrich L; Schmid A; Vogt S; Schumacher YO; Berbalk A; Dickhuth HH
    Herz; 2006 Sep; 31(6):514-8. PubMed ID: 17036181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes.
    Ko GT; Chan JC; Chow CC; Yeung VT; Chan WB; So WY; Ma RC; Ozaki R; Cockram CS
    Acta Diabetol; 2003 Jun; 40(2):80-4. PubMed ID: 12861405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factor measurement quality in primary care routine data was variable but nondifferential between individuals.
    Lyratzopoulos G; Heller RF; Hanily M; Lewis PS
    J Clin Epidemiol; 2008 Mar; 61(3):261-267. PubMed ID: 18226749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study.
    Nantz MP; Rowe CA; Bukowski JF; Percival SS
    Nutrition; 2009 Feb; 25(2):147-54. PubMed ID: 18848434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Badger Heart Program: health screenings targeted to increase cardiovascular awareness in women at four northern sites in Wisconsin.
    Sanchez RJ; Khalil L
    WMJ; 2005 Aug; 104(6):24-9. PubMed ID: 16218312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular prevention. Go for targeted screening.
    Burden AC; Rouse A
    BMJ; 2010 May; 340():c2866. PubMed ID: 20511315
    [No Abstract]   [Full Text] [Related]  

  • 54. Screening of deep-sea fishermen for cardiovascular disease.
    Gockowski K; Tomaszewski R; Dymnicki P; Wasilewska-Piepiórka A; Kliz J; Cyran A; Kapiszka T; Bojaczuk A; Sokołowski A; Nahorski W
    Bull Inst Marit Trop Med Gdynia; 1988; 39(1-2):31-8. PubMed ID: 3252944
    [No Abstract]   [Full Text] [Related]  

  • 55. The human function curve. With special reference to cardiovascular disorders: part II.
    Nixon PG
    Practitioner; 1976 Dec; 217(1302):935-44. PubMed ID: 796840
    [No Abstract]   [Full Text] [Related]  

  • 56. [Active detection of patients with cardiovascular pathology under polyclinical conditions].
    Gritsiuk AI; Chuvikina VT; Terno VS; Kreminskaia NK; Elenskaia KI
    Ter Arkh; 1979; 51(8):8-12. PubMed ID: 505310
    [No Abstract]   [Full Text] [Related]  

  • 57. [Results of additional studies on the performance-diagnostic screening test].
    Rebohle E; Reimer W; Berg E; Buchecker H; Gewalt I; Klingbeil M; Köhler E; Lindemann R; Meinert G; Mencik M; Nack P; Reum PJ; Schneider D
    Z Gesamte Hyg; 1977 Dec; 23(12):896-9. PubMed ID: 607642
    [No Abstract]   [Full Text] [Related]  

  • 58. Cardiovascular prevention. How Scotland targets.
    Stout JC
    BMJ; 2010 May; 340():c2764. PubMed ID: 20501566
    [No Abstract]   [Full Text] [Related]  

  • 59. [Blood pressure and clinico-chemical findings in 11,471 outpatients].
    Haug H; Loch R
    Verh Dtsch Ges Inn Med; 1975; 81():1713-5. PubMed ID: 1227064
    [No Abstract]   [Full Text] [Related]  

  • 60. [Preparation for the use of an electronic data processing device and documentation sheet for findings in cardiovascular diseases].
    Lazarus T
    Z Gesamte Inn Med; 1973 Mar; 28(6):168-72. PubMed ID: 4709067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.